Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -298 | -1,646 | -1,186 | -614 | -319 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | 1 |
| Other Working Capital | -575 | 692 | 564 | 256 | 305 |
| Other Operating Activity | 171 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-701 | $-952 | $-621 | $-357 | $-14 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | 727 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $727 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 510 | 510 | 285 | N/A |
| Other Financing Activity | 50 | 323 | 0 | 0 | 0 |
| Financing Cash Flow | $50 | $833 | $510 | $285 | $N/A |
| Beginning Cash Position | 17 | 136 | 136 | 136 | 136 |
| End Cash Position | 93 | 17 | 25 | 64 | 122 |
| Net Cash Flow | $76 | $-119 | $-111 | $-72 | $-14 |
| Free Cash Flow | |||||
| Operating Cash Flow | -701 | -952 | -621 | -357 | -14 |
| Free Cash Flow | -701 | -952 | -621 | -357 | -14 |